Back
ESC Professional Premium Access

Does first line AF ablation improve outcome in asymptomatic patients?

Session: When to consider AF ablation: outcome and survival in specific cohorts
Topic: Treatment
Speaker: Professor K. Chun (Frankfurt, DE)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Kyoung-Ryul Julian Chun

Cardioangiologisches Centrum Bethanien, Frankfurt (Germany)
20 presentations
3 followers

4 more presentations in this session

Does first line atrial fibrillation ablation improve survival in HFrEF?

Speaker: Professor J. Piccini (Durham, US)

Access
Slides
Video
Thumbnail

Does first line atrial fibrillation ablation improve survival in HFpEF?

Speaker: Professor G. Hindricks (Berlin, DE)

Access
Slides
Video
Thumbnail

Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

Speaker: Doctor A. Creta (London, GB)

Access
Slides
Video
Thumbnail

When to consider AF ablation: outcome and survival in specific cohorts – discussion.

Access
Video
Thumbnail

Access the full session

When to consider AF ablation: outcome and survival in specific cohorts

Speakers: Professor K. Chun, Professor J. Piccini, Professor G. Hindricks, Doctor A. Creta
Access
Video
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb